DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Supriya Lifescience
03 2AFT Pharmaceuticals
04 2Accord healthcare
05 1Apotex Inc
06 1Aspiro Pharma
07 1Aurobindo Pharma Limited
08 1Baxter Healthcare Corporation
09 2Biological E
10 1Chia Tai Tianqing Pharmaceutical Group
11 1Cipla Medpro South Africa
12 1Etico Lifesciences
13 1Fresenius Kabi USA
14 1GENEYORK PHARMS
15 1Grupo Azevedos
16 1Juno Pharma SA (Pty) Ltd
17 1Lupin Ltd
18 1MERCK CANADA INC
19 2MSD INTL GMBH
20 1MSN Laboratories
21 2Medsurge Healthcare
22 8Merck & Co
23 1Naprod Life Sciences
24 1Navinta
25 1Piramal Enterprises Limited
26 1Polifarma
27 1Praxgen
28 1Qilu Pharmaceutical
29 2Reach Pharmaceuticals
30 1Sagent Pharmaceuticals
31 1Sakar Healthcare
32 1Sandoz B2B
33 1Steriscience
34 1Tecnimede
35 1Teva Pharmaceutical Industries
36 1TherDose Pharma
37 2Viatris
01 1Caps
02 1Dry Sub
03 1Fosaprepitant 150Mg 10 Ml 1 Units Parenteral Use
04 2INF
05 2INJ
06 3Injection
07 1Lyophilised Injection
08 1Lyophilized Injection
09 1POWDER FOR SOLUTION
10 2POWDER FOR SOLUTION FOR INFUSION
11 22POWDER;INTRAVENOUS
12 1Powder for Solution for Injection
13 1Powder for solution for Infusion
14 1Powder for solution for infusion
15 1SOLUTION;INTRAVENOUS
16 1UNKNOWN
17 1Vial
18 8Blank
01 9DISCN
02 3Generic
03 1Originator
04 14RX
05 24Blank
01 2EMEND
02 1EMEND IV
03 1EMETEND 150 mg
04 1Easan
05 1Emend
06 2Emend IV
07 1FOCINVEZ
08 21FOSAPREPITANT DIMEGLUMINE
09 2FOSAPREPITANT MEDSURGE
10 2FOSAPREPITANT MSN
11 2FOSAPREPITANT-AFT
12 1Fosaprepitant Cipla
13 2IVEMEND
14 1IVEMEND 150 mg
15 2Ivemend
16 9Blank
01 8Australia
02 1Canada
03 6India
04 1Italy
05 2Portugal
06 4South Africa
07 2Sweden
08 2Switzerland
09 1Turkey
10 24USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-12-09
Application Number : 211160
Regulatory Info : RX
Registration Country : USA
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-08-26
Application Number : 204025
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 205020
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2021-01-12
Application Number : 210625
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 211860
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 212309
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2021-03-03
Application Number : 212143
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2016-06-09
Application Number : 206197
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 210689
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EMEND
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-01-25
Application Number : 22023
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMEND
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2010-11-12
Application Number : 22023
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 209965
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-08-20
Application Number : 212957
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : UNKNOWN
Dosage Strength : UNKNOWN
Packaging :
Approval Date :
Application Number : 204845
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-12-08
Application Number : 203939
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 210064
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 115MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 204015
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 204015
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 211624
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
